Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118447322 | 11844732 | 2 | F | 200112 | 20160824 | 20151217 | 20160824 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-12160255 | BRISTOL MYERS SQUIBB | 38.00 | YR | F | Y | 0.00000 | 20160824 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118447322 | 11844732 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Oral | 600 MG, QD | Y | 20972 | 600 | MG | CAPSULE | QD | |||||
| 118447322 | 11844732 | 2 | SS | EFAVIRENZ | EFAVIRENZ | 1 | UNK | Y | 20972 | CAPSULE | |||||||||
| 118447322 | 11844732 | 3 | SS | VIDEX | DIDANOSINE | 1 | Oral | 400 MG, QD | 0 | 400 | MG | POWDER FOR ORAL SOLUTION | QD | ||||||
| 118447322 | 11844732 | 4 | SS | VIDEX EC | DIDANOSINE | 1 | Oral | 400 MG, QD | 0 | 400 | MG | GASTRO-RESISTANT CAPSULE, HARD | QD | ||||||
| 118447322 | 11844732 | 5 | SS | ZERIT | STAVUDINE | 1 | Oral | 60 MG, QD | Y | 0 | 60 | MG | ORAL SOLUTION | QD | |||||
| 118447322 | 11844732 | 6 | SS | COMBIVIR | LAMIVUDINEIDOVUDINE | 1 | Oral | 2 DF, UNK | 0 | 2 | DF | ||||||||
| 118447322 | 11844732 | 7 | SS | VIRACEPT | NELFINAVIR MESYLATE | 1 | Oral | 2500 MG, QD | 0 | 2500 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118447322 | 11844732 | 1 | HIV infection |
| 118447322 | 11844732 | 3 | HIV infection |
| 118447322 | 11844732 | 4 | HIV infection |
| 118447322 | 11844732 | 5 | HIV infection |
| 118447322 | 11844732 | 6 | HIV infection |
| 118447322 | 11844732 | 7 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118447322 | 11844732 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118447322 | 11844732 | Live birth | |
| 118447322 | 11844732 | Pre-eclampsia | |
| 118447322 | 11844732 | Pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118447322 | 11844732 | 1 | 20020124 | 0 | ||
| 118447322 | 11844732 | 4 | 20020105 | 0 | ||
| 118447322 | 11844732 | 5 | 20020124 | 0 | ||
| 118447322 | 11844732 | 6 | 20020124 | 0 | ||
| 118447322 | 11844732 | 7 | 20020124 | 0 |